These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 25648911

  • 1. Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
    Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Knowler WC, Rovin BH, Wu H, Klein JB, Mifflin TE, Feldman HI, Vasan RS, Kimmel PL, Kusek JW, Mauer M, CKD Biomarkers Consortium and the RASS Investigators.
    Nephrol Dial Transplant; 2015 Apr; 30(4):599-606. PubMed ID: 25648911
    [Abstract] [Full Text] [Related]

  • 2. Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
    Wheelock KM, Cai J, Looker HC, Merchant ML, Nelson RG, Fufaa GD, Weil EJ, Feldman HI, Vasan RS, Kimmel PL, Rovin BH, Mauer M, Klein JB, CKD Biomarkers Consortium.
    PLoS One; 2017 Apr; 12(7):e0180964. PubMed ID: 28700653
    [Abstract] [Full Text] [Related]

  • 3. Urine inositol pentakisphosphate 2-kinase and changes in kidney structure in early diabetic kidney disease in type 1 diabetes.
    Looker HC, Merchant ML, Rane MJ, Nelson RG, Kimmel PL, Rovin BH, Klein JB, Mauer M, CKD Biomarkers Consortium.
    Am J Physiol Renal Physiol; 2018 Nov 01; 315(5):F1484-F1492. PubMed ID: 30132343
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
    Satirapoj B, Dispan R, Radinahamed P, Kitiyakara C.
    BMC Nephrol; 2018 Sep 21; 19(1):246. PubMed ID: 30241508
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Usefulness of urinary biomarkers to estimate the interstitial fibrosis surface in diabetic nephropathy with normal kidney function.
    González J, Jatem E, Roig J, Valtierra N, Ostos E, Abó A, Santacana M, García A, Segarra A.
    Nephrol Dial Transplant; 2022 Oct 19; 37(11):2102-2110. PubMed ID: 35583251
    [Abstract] [Full Text] [Related]

  • 9. Severity of glomerulopathy predicts long-term urinary albumin excretion rate in patients with type 1 diabetes and microalbuminuria.
    Bangstad HJ, Osterby R, Hartmann A, Berg TJ, Hanssen KF.
    Diabetes Care; 1999 Feb 19; 22(2):314-9. PubMed ID: 10333951
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study.
    Klein R, Zinman B, Gardiner R, Suissa S, Donnelly SM, Sinaiko AR, Kramer MS, Goodyer P, Moss SE, Strand T, Mauer M, Renin-Angiotensin System Study.
    Diabetes; 2005 Feb 19; 54(2):527-33. PubMed ID: 15677511
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes.
    Drummond K, Mauer M, International Diabetic Nephropathy Study Group.
    Diabetes; 2002 May 19; 51(5):1580-7. PubMed ID: 11978659
    [Abstract] [Full Text] [Related]

  • 15. The effect of renal hyperfiltration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes mellitus.
    Har R, Scholey JW, Daneman D, Mahmud FH, Dekker R, Lai V, Elia Y, Fritzler ML, Sochett EB, Reich HN, Cherney DZ.
    Diabetologia; 2013 May 19; 56(5):1166-73. PubMed ID: 23412605
    [Abstract] [Full Text] [Related]

  • 16. Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
    Morii T, Fujita H, Narita T, Koshimura J, Shimotomai T, Fujishima H, Yoshioka N, Imai H, Kakei M, Ito S.
    Ren Fail; 2003 May 19; 25(3):439-44. PubMed ID: 12803507
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Five-year prospective study of glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients.
    Silveiro SP, Friedman R, de Azevedo MJ, Canani LH, Gross JL.
    Diabetes Care; 1996 Feb 19; 19(2):171-4. PubMed ID: 8718441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.